BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10328421)

  • 21. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes.
    Ogawa S; Takeuchi K; Ito S
    Diabetes Obes Metab; 2004 Sep; 6(5):384-90. PubMed ID: 15287932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of acarbose as monotherapy in NIDDM patients.
    Deerochanawong C; Serirat S; Kornthong P
    J Med Assoc Thai; 1996 Feb; 79(2):69-75. PubMed ID: 8868016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of sucrose meal on insulin requirement in IDDM and its modulation by acarbose.
    Lecavalier L; Hamet P; Chiasson JL
    Diabete Metab; 1986 Jun; 12(3):156-61. PubMed ID: 3525270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
    Azuma K; Toyofuku Y; Iesaki T; Otsuka A; Tanaka A; Mita T; Hirose T; Tanaka Y; Daida H; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2006 Jun; 345(2):688-93. PubMed ID: 16696939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
    Chiasson JL
    Diabet Med; 1996; 13(3 Suppl 2):S23-4. PubMed ID: 8689858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the safety and efficacy of acarbose in diabetes mellitus.
    Yee HS; Fong NT
    Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage.
    Frati Munari AC; Benítez Pinto W; Raúl Ariza Andraca C; Casarrubias M
    Arch Med Res; 1998; 29(2):137-41. PubMed ID: 9650328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S; Turco S; Guarino G; Oliviero B; Rustici A; Torella R
    Ann Ital Med Int; 1999; 14(1):7-14. PubMed ID: 10528419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of glucosidase inhibitor, Bay g 5421 (acarbose), on the blood glucose in obese diabetic patients ty pe 2 (NIDDM) (author's transl)].
    Laube H; Fouladfar M; Aubell R; Schmitz H
    Arzneimittelforschung; 1980; 30(7):1154-7. PubMed ID: 7191299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
    Koch HH; Wudy A; Eberlein G; Quast C
    Diabetes Nutr Metab; 1999 Jun; 12(3):195-201. PubMed ID: 10554902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
    Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
    Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of acarbose and simultaneous antacid therapy on blood glucose.
    Höpfner M; Durani B; Spengler M; Fölsch UR
    Arzneimittelforschung; 1997 Oct; 47(10):1108-11. PubMed ID: 9368703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose acarbose does not delay digestion of starch but reduces its bioavailability.
    Wachters-Hagedoorn RE; Priebe MG; Heimweg JA; Heiner AM; Elzinga H; Stellaard F; Vonk RJ
    Diabet Med; 2007 Jun; 24(6):600-6. PubMed ID: 17381499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Short term assessment of anthropometric indices and metabolic parameters in obese subjects treated with acarbose].
    Coli P; Pea E; Lacorte M; Passaglia C; Carrai M
    Minerva Med; 1996 Apr; 87(4):161-70. PubMed ID: 8700340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a nutritional supplement containing Salacia oblonga extract and insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults.
    Collene AL; Hertzler SR; Williams JA; Wolf BW
    Nutrition; 2005; 21(7-8):848-54. PubMed ID: 15975493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.
    Hermanns N; Burkert A; Haak T
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):310-4. PubMed ID: 15216448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
    Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
    Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J; Soszyński P
    Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of methanol extract of Rosa damascena Mill. flowers on alpha-glucosidase activity and postprandial hyperglycemia in normal and diabetic rats.
    Gholamhoseinian A; Fallah H; Sharifi far F
    Phytomedicine; 2009 Oct; 16(10):935-41. PubMed ID: 19380218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.